Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia (2015)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.jacl.2014.12.008
- Subjects: HIPERCOLESTEROLEMIA; LIPOPROTEÍNAS; OLIGOPEPTÍDEOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of clinical lipidology
- ISSN: 1933-2874
- Volume/Número/Paginação/Ano: v. 9, n. 2, p. 201-209, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc-nd
-
ABNT
SANTOS, Raul D. et al. Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia. Journal of clinical lipidology, v. 9, n. 2, p. 201-209, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.jacl.2014.12.008. Acesso em: 02 jan. 2026. -
APA
Santos, R. D., Raal, F. J., Donovan, J. M., & Crowell, W. C. (2015). Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia. Journal of clinical lipidology, 9( 2), 201-209. doi:10.1016/j.jacl.2014.12.008 -
NLM
Santos RD, Raal FJ, Donovan JM, Crowell WC. Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia [Internet]. Journal of clinical lipidology. 2015 ; 9( 2): 201-209.[citado 2026 jan. 02 ] Available from: https://doi.org/10.1016/j.jacl.2014.12.008 -
Vancouver
Santos RD, Raal FJ, Donovan JM, Crowell WC. Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia [Internet]. Journal of clinical lipidology. 2015 ; 9( 2): 201-209.[citado 2026 jan. 02 ] Available from: https://doi.org/10.1016/j.jacl.2014.12.008 - Foi com muita satisfação que recebemos o convite dos ...[Apresentação]
- Relation of Uric Acid to Serum Levels of High-Sensitivity C-Reactive Protein, Triglycerides, and High-Density Lipoprotein Cholesterol and to Hepatic Steatosis
- Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment
- Elevated uric acid, the metabolic syndrome and cardiovascular disease [Editorial]: cause, consequence, or just a not so innocent bystander?
- Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta]
- Statin Use Is Not Associated With Presence of and Severity of Nonalcoholic Fatty Liver Disease
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
- What are we able to achieve today for our patients with homozygous familial hypercholesterolaemia, and what are the unmet needs?
Informações sobre o DOI: 10.1016/j.jacl.2014.12.008 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
